BDSX
Income statement / Annual
Last year (2023), Biodesix, Inc.'s total revenue was $49.09 M,
an increase of 28.46% from the previous year.
In 2023, Biodesix, Inc.'s net income was -$52.15 M.
See Biodesix, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
Operating Revenue |
$49.09 M
|
$38.21 M
|
$54.51 M
|
$45.56 M
|
$24.55 M
|
$20.43 M
|
Cost of Revenue |
$15.88 M |
$14.15 M |
$30.52 M |
$22.00 M |
$6.07 M |
$4.41 M |
Gross Profit |
$33.21 M |
$24.06 M |
$23.99 M |
$23.56 M |
$18.48 M |
$16.03 M |
Gross Profit Ratio |
0.68 |
0.63 |
0.44 |
0.52 |
0.75 |
0.78 |
Research and Development
Expenses |
$9.99 M
|
$13.10 M
|
$12.79 M
|
$10.82 M
|
$10.47 M
|
$8.19 M
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$30.64 M
|
$25.90 M
|
Selling & Marketing
Expenses |
$0.00
|
$61.46 M
|
$50.52 M
|
$34.86 M
|
$30.64 M
|
$25.90 M
|
Selling, General &
Administrative Expenses |
$64.52 M
|
$61.46 M
|
$50.52 M
|
$34.86 M
|
$30.64 M
|
$25.90 M
|
Other Expenses |
$6,000.00 |
$109,000.00 |
-$9,000.00 |
$422,000.00 |
-$2.38 M |
-$1.24 M |
Operating Expenses |
$74.51 M |
$74.56 M |
$63.31 M |
$45.68 M |
$41.11 M |
$34.09 M |
Cost And Expenses |
$90.39 M |
$88.72 M |
$93.82 M |
$67.67 M |
$47.18 M |
$38.49 M |
Interest Income |
$0.00 |
$8.07 M |
$4.51 M |
$18,000.00 |
$55,000.00 |
$24,000.00 |
Interest Expense |
$9.54 M |
$8.07 M |
$4.51 M |
$7.60 M |
$3.01 M |
$2.92 M |
Depreciation &
Amortization |
$5.51 M
|
$3.60 M
|
$3.18 M
|
$2.90 M
|
$2.79 M
|
$1.74 M
|
EBITDA |
-$35.79 M
|
-$50.40 M
|
-$39.33 M
|
-$21.68 M
|
-$22.16 M
|
-$17.53 M
|
EBITDA Ratio |
-0.73 |
-1.32 |
-0.72 |
-0.48 |
-0.9 |
-0.86 |
Operating Income Ratio
|
-0.84
|
-1.32
|
-0.72
|
-0.49
|
-0.92
|
-1.15
|
Total Other
Income/Expenses Net |
-$10.85 M
|
-$14.94 M
|
-$3.84 M
|
-$9.23 M
|
-$8.10 M
|
-$5.21 M
|
Income Before Tax |
-$52.15 M |
-$65.45 M |
-$43.16 M |
-$31.35 M |
-$30.73 M |
-$26.17 M |
Income Before Tax Ratio
|
-1.06
|
-1.71
|
-0.79
|
-0.69
|
-1.25
|
-1.28
|
Income Tax Expense |
$5.34 M |
$14.94 M |
$1.32 M |
$5.12 M |
$629,000.00 |
$211,000.00 |
Net Income |
-$52.15 M |
-$80.39 M |
-$44.48 M |
-$36.47 M |
-$31.36 M |
-$26.17 M |
Net Income Ratio |
-1.06 |
-2.1 |
-0.82 |
-0.8 |
-1.28 |
-1.28 |
EPS |
-0.64 |
-1.91 |
-1.63 |
-1.37 |
-123 |
-1 |
EPS Diluted |
-0.64 |
-1.91 |
-1.63 |
-1.37 |
-123 |
-1 |
Weighted Average Shares
Out |
$82.11 M
|
$42.10 M
|
$27.37 M
|
$26.56 M
|
$254,917.00
|
$26.13 M
|
Weighted Average Shares
Out Diluted |
$82.11 M
|
$42.10 M
|
$27.37 M
|
$26.56 M
|
$254,917.00
|
$26.13 M
|
Link |
|
|
|
|
|
|